| Revenue | NOK 3M | — |
| EBITDA | NOK -2,3M | -395% |
| Net profit | NOK -2,3M | -524% |
| Total assets | NOK 345,7M | +482% |
| Equity | NOK 233M | +15988% |
| Employees | 0 | — |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 3 010 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −485 | −347 | −751 | −1 107 | −465 | −2 300 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −618 |
| EBIT | −485 | −347 | −751 | −1 107 | −465 | −2 917 |
| Net financials | 1 | 0 | 0 | −0 | 0 | 0 |
| Profit before tax | −484 | −346 | −751 | −1 107 | −465 | −2 917 |
| Tax | −107 | −76 | −165 | −240 | −99 | −635 |
| Net profit | −378 | −270 | −586 | −867 | −366 | −2 282 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Total assets | 5 986 | 13 686 | 19 245 | 38 165 | 59 429 | 345 732 |
| Equity | 622 | 352 | −234 | −1 100 | −1 466 | 232 952 |
| Long-term debt | 3 000 | 12 000 | 18 557 | 37 298 | 52 689 | 95 892 |
| Short-term debt | 2 364 | 1 334 | 922 | 1 968 | 8 206 | 16 888 |
| Total debt | 5 364 | 13 334 | 19 479 | 39 266 | 60 895 | 112 780 |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
OD Deputy Member | Deputy Member | 2021 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2021 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2021 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Allstad Næringseiendom As | Company | 70.0% | 70.0% | 2024 |
Stiftelsen Oslo Hospital | Company | 30.0% | 30.0% | 2024 |
| Person | Role here | Other companies |
|---|---|---|
| Olav Dag Hauge | Deputy Member | 0 companies |
| Bernt Nordby Skøien | Chairman | 0 companies |
| Michael Von Tetzschner | Board of Directors | 0 companies |
| Morten Lars Herlofsen | Board of Directors | 0 companies |
| Are Erling Njåstein | Board of Directors | 0 companies |